|
| Friday, 16 October 2020, 09:00 HKT/SGT | |
| |
|
|
|
|
Names Ms. Yeh-Huang, Chun-Ying as Vice Chairman of the Board
Appoints Dr. Liu, Jun as Chief Executive Officer |
HONG KONG, Oct 16, 2020 - (ACN Newswire) - TOT BIOPHARM International Company Limited ("TOT BIOPHARM" or the "Company"; stock code: 1875.HK), is pleased to announce that Ms. Yeh-Huang, Chun-Ying, Executive Director, has been appointed as Vice Chairman of the Board while she has resigned as General Manager of the Company. Besides, it has also announced that Dr. Liu, Jun has been appointed as Chief Executive Officer of the Company and will cease to act as Chief Operating Officer and Vice General Manager.
Mr. Fu, Shan, Chairman of the Board of the Company, said, "To implement the strategic development plan of the Company in the next decade, the appointments of the Board and the management will be conducive to optimising the Company's management structure, or initiating a long-term succession plan for the management, so that the Company will achieve long-term sustainable development and be fully equipped to enter the commercialization development stage. Also, this move will enhance the development of the Company's overseas R&D projects and international cooperation projects, promoting its strategic deployment of internationalization."
Ms. Yeh-Huang has established a comprehensive industrial chain platform for the Company, laying major milestones as well as a solid foundation for its long-term development. She will also continue to promote the Company's strategic development, enhancing its brand recognition and public relations.
As a scientist and senior management of the Company, Dr. Liu has been deeply involved in the R&D of biological drugs for years and also possesses profound experience in internationalization management. After taking the helm of CEO, the Board believes that Dr. Liu will continue to pursue the Company's strategic goal of developing TOT BIOPHARM into a leader in the field of China's antibody drug conjugate ("ADC") and establish a competitive CDMO business platform, leading the Company to scale new heights.
Dr. Liu, Jun, aged 53, joined the Company as Deputy General Manager in October 2016, and was appointed as Executive Director, Chief Scientific Officer and Chief Operating Officer in October 2018, March 2019 and April 2020, respectively. He also serves as a member of the Strategic Committee, and is responsible for the Company's R&D, supervising overall operations as well as business development.
Before joining the Company, Dr. Liu was the Senior Scientist of Bayer HealthCare's Global Biologics Development Group in Berkeley, the US, the Chief Researcher of Immunology Department at Beckman Research Institute in California, the US, and also the Executive Director of Biologics Research and Development Department at Shanghai ChemPartner Co., Ltd.
Dr. Liu possesses a professional background with international exposure, holding a PhD in Bioanalytical Chemistry from the University of California, Davis in the US and a Bachelor's degree in Chemistry from the University of Science & Technology of China.
Topic: Press release summary
Sectors: Daily Finance, Daily News, BioTech, Healthcare & Pharm
https://www.acnnewswire.com
From the Asia Corporate News Network
Copyright © 2026 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.
|
|
|
|
|
|
|
| |
Latest Press Releases
4th ASEAN Procurement Innovation Summit & Awards 2026
Apr 17, 2026 08:50 HKT/SGT
|
|
|
Mitani Sangyo Filed U.S. Patent Application for AI Reliability Governance Framework
Thursday, April 16, 2026 11:00:00 PM
|
|
|
Datavault AI Goes Live with First Edge GPU Sites in New York and Philadelphia; $1.44B-$1.92B Quantum-Ready Fleet to Reach 100+ U.S. Cities by End of 2026
Apr 16, 2026 21:50 HKT/SGT
|
|
|
TANAKA PRECIOUS METAL NEXT Certified as a Special Subsidiary
Thursday, April 16, 2026 8:00:00 PM
|
|
|
InnoEX and Electronics Fair (Spring Edition) attract over 88,000 global buyers
Apr 16, 2026 19:58 HKT/SGT
|
|
|
Focus Graphite Appoints Former Chief of the Defence Staff General Wayne Eyre to Advisory Board
Apr 16, 2026 17:58 HKT/SGT
|
|
|
Isuzu and Toyota to Jointly Develop Japan's First Mass-produced Light-duty Fuel Cell Electric Truck
Thursday, April 16, 2026 2:53:00 PM
|
|
|
Honda to Begin Sales of All-new Insight EV
Thursday, April 16, 2026 2:31:00 PM
|
|
|
3 Years and 11 Months! 'AI+All-in-One PV Storage' Sigenergy Listed on HKEX: Fastest IPO Record for a Chinese Enterprise
Apr 16, 2026 11:31 HKT/SGT
|
|
|
GMG Doubles Energy Density of 6 Minute Charging Graphene Aluminium-Ion Battery
Apr 15, 2026 19:59 HKT/SGT
|
|
|
|
|
More Press release >> |
|
|
|
